ArticlemedRxiv : the preprint server for health sciences2026

Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.

PREVAC study TeamPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.